RAFAEL HOLDINGS, INC. Other General Expense
RAFAEL HOLDINGS, INC. (RFL) reported Other General Expense of $157.00 thousand for the 12-month period ending 2022-07-31, per its 10-K filed 2022-10-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherGeneralExpense · last filed 2022-10-31
- RAFAEL HOLDINGS, INC. other general expense for fiscal 2022 was $157.00K.
| Period end | Other General Expense 12 month |
|---|---|
| 2022-07-31 | $157.00K 10-K · filed 2022-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |